Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

IMPORTANCE: American College of Cardiology/American Heart Association cholesterol guidelines prioritize primary prevention statin therapy based on 10-year absolute risk (AR(10)) of atherosclerotic cardiovascular disease (ASCVD). However, given the same AR(10), patients with higher levels of low-dens...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Cardiol
Autori principali: Kohli-Lynch, Ciaran N., Bellows, Brandon K., Thanassoulis, George, Zhang, Yiyi, Pletcher, Mark J., Vittinghoff, Eric, Pencina, Michael J., Kazi, Dhruv, Sniderman, Allan D., Moran, Andrew E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2019
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714024/
https://ncbi.nlm.nih.gov/pubmed/31461121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.2851
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi